Direxion Daily S&P Biotech Bear 3X Shares
NYSE Arca:LABD

  • LAST PRICE
    6.15
  • TODAY'S CHANGE (%)
    0.24 (4.06%)
  • Bid / Lots
    6.13/ 9
  • Ask / Lots
    6.15/ 5
  • Open / Previous Close
    6.00 / 5.91
  • Day Range
    5.94
    6.20
  • 52 Week Range
    5.11
    29.92
  • Volume
    15,223,769
  • Overall Morningstar Rating
    Not Ratedout of funds

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Daily Premium/Discount

Bar Graph.See accessible table below
ETFs trading at a price higher than its Net Asset Value (NAV) is said to be trading at a premium, while those trading at price lower than its NAV is said to be at a discount. By showing the daily premium/discount percentage, we can see the trend in market sentiments, regarding the value of an ETF over time.

Holdings Diversification

Asset Class
Other		56.5%
Cash		49.1%
Convertible		0
Non-US Bond		0
Non-US Stock		0
Preferred		0
Sectors
No data available
Geographic Region
No data available
As of 2024-10-31

Top 10 Holdings

No data available

Reports

No reports available

Morningstar Ratings

Time HorizonStar Rating
Overall RatingNot Rated
3 Year RatingNot Rated
5 Year RatingNot Rated
10 Year RatingNot Rated
As of 2024-09-30

Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.

Style Box is calculated only using the long position holdings of the portfolio.

ETF Profile
Best Fit Index
---
Category
Trading--Inverse Equity
Sponsor
Rafferty Asset Management, LLC
Inception
May 28, 2015
As of 2024-09-30

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. The fund is non-diversified.

Holding Details
Total Net Assets$99.6M
Shares Out.13.8M
Net Asset Value (NAV)$5.92
Prem/Discount to NAV-0.15%
P/E Ratio---
Dividend Yield4.84%
Dividend per Share0.30 USD
Ex-Dividend Date09/24/2024
Dividend Payment Date10/1/2024
Beta---
Morningstar Investment StyleTrading--Inverse Equity
Equity Style
---
Credit Quality / Duration
---
Fees & Expenses
Actual Management Fee0.75%
Actual Mgmt. Expense Ratio (MER)1.61%